Strategy update & notice of investor presentation

AI SummaryClose X

Novacyt S.A. anticipates a slight increase in H2 2025 revenues compared to H1 2025, driven by instrument sales. The Group expects an improved EBITDA loss for 2025 compared to the £9.1m loss reported in FY24, supported by a better gross margin. Cash outflow is also projected to improve in H2 2025, being lower than the H1 2025 outflow of £6.8m, due to completed site consolidation. The company aims for double-digit revenue growth year-on-year from FY26 and a gross margin above 60% each year, noting a H1 FY25 gross margin of 66%. Novacyt also intends to achieve EBITDA profitability based on organic growth plans. The company agreed to invest up to £2m per year from 2025-2027 to accelerate new product introductions.

Disclaimer*

UK 100

Latest directors dealings